English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Dr Stephen Hanson in 2007 to develop new drug delivery approaches for preserving the lifespan of synthetic vascular grafts. Dr Ronald Shebuski was appointed as President of Cylerus in 2010, bringing a wealth of experience in biotechnology development. Also, part of the team is Drs Prabir Roy-Chaudhury, Diego Celdran, and Heidi Mansour (U AZ-Tucson) and Dr Sandra Rugonyi (OHSU, Portland, OR). The vision of the company is to have a positive impact in the haemodialysis graft access market within a short time frame once their novel drug delivery device is commercialised.

Local drug delivery to prosthetic vascular grafts: Preventing failure of prosthetic grafts in haemodialysis patients